PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.94%
Revenue growth under 50% of NEM's 6.72%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.70%
Gross profit growth under 50% of NEM's 14.09%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.01%
Negative EBIT growth while NEM is at 12.96%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.01%
Negative operating income growth while NEM is at 12.96%. Joel Greenblatt would press for urgent turnaround measures.
2.54%
Net income growth under 50% of NEM's 16.28%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.78%
EPS growth under 50% of NEM's 15.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.78%
Diluted EPS growth under 50% of NEM's 15.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.13%
Share change of 0.13% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.13%
Diluted share count expanding well above NEM's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-6.78%
Negative OCF growth while NEM is at 18.31%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
97.38%
FCF growth above 1.5x NEM's 31.22%. David Dodd would verify if the firm’s strategic investments yield superior returns.
33.15%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
50.97%
5Y revenue/share CAGR above 1.5x NEM's 7.96%. David Dodd would look for consistent product or market expansions fueling outperformance.
53.17%
3Y revenue/share CAGR above 1.5x NEM's 22.71%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
0.93%
10Y OCF/share CAGR under 50% of NEM's 48.94%. Michael Burry would worry about a persistent underperformance in cash creation.
56.40%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
57.62%
3Y OCF/share CAGR at 75-90% of NEM's 65.94%. Bill Ackman would press for improvements in margin or overhead to catch up.
-11.94%
Negative 10Y net income/share CAGR while NEM is at 3.58%. Joel Greenblatt sees a major red flag in long-term profit erosion.
167.29%
Below 50% of NEM's 1928.71%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-48.58%
Negative 3Y CAGR while NEM is 48.12%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.57%
10Y equity/share CAGR above 1.5x NEM's 0.03%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
19.17%
Below 50% of NEM's 46.04%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
11.80%
Below 50% of NEM's 43.01%. Michael Burry suspects a serious short-term disadvantage in building book value.
666.81%
10Y dividend/share CAGR above 1.5x NEM's 174.10%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
173.48%
Below 50% of NEM's 2156.11%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
57.86%
Below 50% of NEM's 295.65%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
139.98%
AR growth well above NEM's 29.66%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.95%
Inventory is declining while NEM stands at 1.93%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.89%
Positive asset growth while NEM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.93%
BV/share growth above 1.5x NEM's 0.43%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
68.08%
We expand SG&A while NEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.